Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGXSWX:DSFIR +0.11%31 3-Year EBITDA Growth Rate is 37.60% as of Jun. 2026, which is at its 10-year median of 37.60. GuruFocus rates XSWX:DSFIR with a GF Score™ of 31/100 and a GF Value™ of CHF78.44 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,406 Chemicals companies, DSM-Firmenich AG ranks better than 90.83% on this metric.
During the past 12 months, DSM-Firmenich AG's average EBITDA Per Share Growth Rate was 101.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 37.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of DSM-Firmenich AG was 37.60% per year. The lowest was 37.60% per year. And the median was 37.60% per year.
DSM-Firmenich AG (XSWX:DSFIR) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
DSM-Firmenich AG 3-Year EBITDA Growth Rate Related Terms
XSWX:DSFIR vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, DSM-Firmenich AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's 3-Year EBITDA Growth Rate falls into.
DSM-Firmenich AG 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 37.60% mean?
DSM-Firmenich AG (XSWX:DSFIR) has a 3-Year EBITDA Growth Rate of 37.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for DSM-Firmenich AG and its competitors. This is near median its historical median of 37.60. Over the past decade, DSM-Firmenich AG's 3-Year EBITDA Growth Rate has ranged from 37.60 to 37.60. According to the industry distribution chart, DSM-Firmenich AG ranks #129 out of 1406 companies in the Chemicals industry, placing it in the top 9.2%.
Is DSM-Firmenich AG's 3-Year EBITDA Growth Rate too high?
DSM-Firmenich AG's current 3-Year EBITDA Growth Rate of 37.60% is near median its 10-year median of 37.60. Over the past 10 years, this metric has ranged from a low of 37.60 to a high of 37.60. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. DSM-Firmenich AG's value of 37.60% is 4600% above this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #129 out of 1406 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #129 out of 1406 companies for 3-Year EBITDA Growth Rate. This places DSM-Firmenich AG in the top 9% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. DSM-Firmenich AG's value of 37.60% is 4600% above this benchmark. Historically, DSM-Firmenich AG's own 3-Year EBITDA Growth Rate has ranged from 37.60 to 37.60 over the past decade. While the company's 10-year median is 37.60 vs. the industry median of 0.80, DSM-Firmenich AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,406 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current 3-Year EBITDA Growth Rate of 37.60% is 4600% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for DSM-Firmenich AG and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current 3-Year EBITDA Growth Rate is 37.60%, which is near median its own 10-year median of 37.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF78.44, compared to a current price of CHF87.90 — trading 12.1% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 37.60%, which is near median its 10-year median of 37.60 and 4600% above the Chemicals industry median of 0.80. DSM-Firmenich AG's overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current 3-Year EBITDA Growth Rate is 37.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF87.90 is trading 12.1% above its estimated GF Value™ of CHF78.44.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for XSWX:DSFIR:
3-Year EBITDA Growth Rate: 37.60% (near median its 10-year median of 37.60)
GF Value™: CHF78.44 vs. price of CHF87.90 (12.1% above fair value)
Industry Position: 4600% above the Chemicals median (#129 of 1406)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score
Get the complete analysis for XSWX:DSFIR
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 
